|

MDN-001 Injection(Yttrium-90 Microsphere Injection) Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • Suzhou Mednovo Yi Medical Technology Co., Ltd.1

Indications

  • Liver Disease1
  • Unresectable Hepatocellular Carcinoma (HCC)1
  • Hepatoma1
  • Liver Cancer1
  • Cancer1

Other1 trial

MDN-001 Injection for the Treatment of Unresectable Primary Hepatocellular Carcinoma.
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.